Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does REZAFUNGIN Cause Off label use? 48 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Off label use have been filed in association with REZAFUNGIN (REZZAYO). This represents 44.4% of all adverse event reports for REZAFUNGIN.

48
Reports of Off label use with REZAFUNGIN
44.4%
of all REZAFUNGIN reports
2
Deaths
3
Hospitalizations

How Dangerous Is Off label use From REZAFUNGIN?

Of the 48 reports, 2 (4.2%) resulted in death, 3 (6.3%) required hospitalization.

Is Off label use Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for REZAFUNGIN. However, 48 reports have been filed with the FAERS database.

What Other Side Effects Does REZAFUNGIN Cause?

No adverse event (12) Product prescribing issue (12) Hypokalaemia (6)

What Other Drugs Cause Off label use?

RITUXIMAB (39,751) INFLIXIMAB (34,801) DENOSUMAB (34,612) METHOTREXATE (24,020) VEDOLIZUMAB (21,017) ETANERCEPT (20,178) TOCILIZUMAB (18,256) PREDNISONE (17,867) LENALIDOMIDE (17,017) ADALIMUMAB (16,417)

Which REZAFUNGIN Alternatives Have Lower Off label use Risk?

REZAFUNGIN vs RIBASPHERE REZAFUNGIN vs RIBAVIRIN REZAFUNGIN vs RIBOCICLIB REZAFUNGIN vs RIBOFLAVIN REZAFUNGIN vs RIBOFLAVIN 5'-PHOSPHATE

Related Pages

REZAFUNGIN Full Profile All Off label use Reports All Drugs Causing Off label use REZAFUNGIN Demographics